Curi Bio Revenue and Competitors
Estimated Revenue & Valuation
- Curi Bio's estimated annual revenue is currently $3.7M per year.
- Curi Bio's estimated revenue per employee is $77,500
- Curi Bio's total funding is $16M.
Employee Data
- Curi Bio has 48 Employees.
- Curi Bio grew their employee count by -21% last year.
Curi Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & CBO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Research & Partnerships | Reveal Email/Phone |
4 | Director Operations | Reveal Email/Phone |
5 | Director Therapeutic Assays | Reveal Email/Phone |
6 | Director Sales and Marketing | Reveal Email/Phone |
7 | Director, Biosystems Engineering | Reveal Email/Phone |
8 | Project Manager - Scientific Services | Reveal Email/Phone |
9 | Product Manager | Reveal Email/Phone |
10 | Manager, R&D Operations | Reveal Email/Phone |
Curi Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Curi Bio?
Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.
keywords:N/A
$16M
Total Funding
48
Number of Employees
$3.7M
Revenue (est)
-21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Curi Bio News
... to start a new position with Seattle-based biotech Curi Bio, ... "Christos is someone who understands the biology," says White,...
Curi Bio's preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi...
Curi Bio Inc., a Seattle, WA-based developer of human stem cell-based platforms for drug discovery, raised $6m in Series A financing round. The round, led by Dynamk Capital, is expected to close with additional investors by the end of Q2 2021. With this financing round, Dr. Gustavo Mahler, Mana ...
Curi Bio Chief Business Officer Elliot Fisher and CEO Michael Cho. (Curi Bio Photos) New funding: Curi Bio raised $6 million to further develop its human stem cell-based platforms for drug discovery. Dynamk Capital led the Series A round. Total funding to date is $16.8 million. Company backgro ...
SEATTLE, March 18, 2021 /PRNewswire/ -- Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced today it has raised $6 million in a Series A financing round. The round, led by Dynamk Capital, is expected to close with additional investors by the end of ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.6M | 48 | 0% | N/A |
#2 | $9.7M | 48 | 4% | N/A |
#3 | $1.7M | 48 | 7% | N/A |
#4 | $5.6M | 48 | N/A | N/A |
#5 | $5.6M | 48 | N/A | N/A |